Physical activity and gynecologic cancer survivorship

Recent Results in Cancer Research

Volumn 186, Issue , 2011, Pages 305-315

  Gil, Karen M ^a,b   Von Gruenigen, Vivian E ^b,c,d  

^a AKRON GENERAL MEDICAL CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c Department of Obstetrics and Gynecology ^*  (United States)

^d SUMMA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PACLITAXEL;

CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; ENDOMETRIUM CANCER; GYNECOLOGIC SURGERY; HUMAN; LIFESTYLE; MORTALITY; MULTIPLE CYCLE TREATMENT; OBESITY; OVARY CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SURVIVAL TIME;

ENDOMETRIAL NEOPLASMS; EXERCISE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; OBESITY; OVARIAN NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 78649944557     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-04231-7_13     Document Type: Review

References (37)

1. American Cancer Society, www.cancer.org, accessed January 12, 2010
2. Pomel C, Jeyarajah A, Oram D, Shepherd J, Milliken D, Dauplat J, Reynolds K (2007) Cytoreductive surgery in ovarian cancer. Cancer Imaging 7:210-215
3. Winter WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F, McGuire WP (2007) Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25(24):24-3627
4. Ozols RF (2006) Challenges for chemotherapy in ovarian cancer. Ann Oncol 17(Suppl 5):v181-v187
5. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA (2006) Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354(1):1-43
6. Markman M (2008) Pharmaceutical management of ovarian cancer: current status. Drugs 68(6):6-789
7. Bandera EV, Kushi LH, Rodriguez-Rodriguez L (2009) Nutritional factors in ovarian cancer survival. Nutr Cancer 61(5):5-586
8. Irwin ML, Mayne ST (2008) Impact of nutrition and exercise on cancer survival. Cancer J 14(6):6-441
9. Speed-Andrews AE, Courneya KS (2009) Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep 8(4):4-181
10. Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH (2010). An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):2-100
11. Colditz GA, Coakley E (1997) Weight, weight gain, activity, and major illnesses: the Nurses' Health Study. Int J Sports Med 18 (Suppl 3):S162-170
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 348(17):17-1638
13. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11(9):9-828 (Pubitemid 35014884)
14. Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ (2006) Effect of obesity on survival in epithelial ovarian cancer. Cancer 107(7):7-1524
15. Yang L, Klint A, Lambe M, Bellocco R, Riman T, Bergfeldt K, Persson I, Weiderpass E (2008) Predictors of ovarian cancer survival: A population-based prospective study in Sweden. Int J Cancer 123:672-679
16. Kjaerbye-Thygesen A, Frederiksen K, Høgdall EV, Glud E, Christensen L, Høgdall CK, Blaakaer J, Kjaer SK (2006) Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15(4):4-803
17. Zhang M, Xie X, Lee AH, Binns CW, Holman CD (2005) Body mass index in relation to ovarian cancer survival. Cancer Epidemiol Biomarkers Prev 14(5):5-1310
18. Stevinson C, Steed H, Faught W, Tonkin K, Vallance JK, Ladha AB, Schepansky A, Capstick V, Courneya KS (2009) Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning. Int J Gynecol Cancer 19(1):1-8
19. Wenzel L, Huang HQ, Monk BJ, Rose PG, Cella D (2005) Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 23(24):24-5612
20. Gil KM, Gibbons HE, Jenison EL, Hopkins MP, von Gruenigen VE (2007) Baseline characteristics infuencing quality of life in women undergoing gynecologic oncology surgery. Health Qual Life Outcomes 5:25
21. von Gruenigen V, Frasure H, Kavanagh M, Nieves-Arriba L, Lerner E, Waggoner S, Courneya K (2010) Physical activity may improve quality of life in women with ovarian cancer on adjuvant chemotherapy. Gynecol Oncol 116(3):S140
22. Doyle C, Kushi L, Byers T et al (2006) Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide to informed choices. CA Cancer J Clin 56:323-353
23. von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L (2009). Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials. Cancer 15; 115(20):20-4864
24. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335(7630):7630
25. Conroy MB, Sattelmair JR, Cook NR, Manson JE, Buring JE, Lee IM (2009) Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control 20(7):7-1115
26. Friedenreich C, Cust A, Lahmann PH et al (2007) Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer 121(2):2-355 (Pubitemid 46917704)
27. Gierach GL, Chang SC, Brinton LA, Lacey JV Jr, Hollenbeck AR, Schatzkin A, Leitzmann MF (2009) Physical activity, sedentary behavior, and endometrial cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 124(9):9-2147
28. Patel AV, Feigelson HS, Talbot JT, McCullough ML, Rodriguez C, Patel RC, Thun MJ, Calle EE (2008) The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int J Cancer 123(8):8-1882
29. von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR (2006) Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: A Gynecologic Oncology Group study. Cancer 107(12):12-2791
30. Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH, Fleming GF (2007) Gynecologic Oncology Group. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: A Gynecologic Oncology Group study. Gynecol Oncol 105(1):1-65
31. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE (2009) Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 114(1):121-127
32. Fader AN, Gibbons H, Gil K (2008) von Gruenigen. The impact of obesity on health-related quality of life in endometrial cancer survivors. Gynecol Oncol 108(3):S7-S8
33. Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS (2005) Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 97(2):2-430
34. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Taylor CC (2009). Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):3.e1-8
35. von Gruenigen VE, Gil KM, Frasure HE, Jenison EL, Hopkins MP (2005) The impact of obesity and age on quality of life in gynecologic surgery. Am J Obstet Gynecol 193(4):4-1375
36. von Gruenigen VE, Courneya KS, Gibbons HE, Kavanagh MB, Waggoner SE, Lerner E (2008) Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial. Gynecol Oncol 109(1):1-26
37. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289(1):1-79